ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Pulmonary Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,511Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 118

$1.89M Total Retail Price of All Prescriptions

Rank: 2 out of 118

677 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

17% of this provider’s 677 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

6% of this provider’s 677 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Risky Drugs to Seniors

1% of this provider’s 23,210 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 64%.

Prescription Price

$74 was the average price of a prescription from this provider, compared to $170 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
FUROSEMIDE 1,096 1,026 1 7
WARFARIN SODIUM 814 763 2 15
SIMVASTATIN 644 622 3 8
METOPROLOL TARTRATE 636 567 4 16
OMEPRAZOLE 634 576 5 11
AMLODIPINE BESYLATE 616 610 6 9
LISINOPRIL 557 516 7 12
LEVOTHYROXINE SODIUM 550 526 8 10
TRAZODONE HCL 495 493 9 27
DONEPEZIL HCL 447 442 10 31
CITALOPRAM HBR 432 405 11 36
POTASSIUM CHLORIDE 408 380 12 29
SERTRALINE HCL 381 374 13 33
ADVAIR DISKUS 360 326 14 2
CYMBALTA 356 329 15 45
SPIRIVA 340 293 16 1
MIRTAZAPINE 334 294 17 43
GABAPENTIN 326 288 18 25
QUETIAPINE FUMARATE 308 290 19 44
PREDNISONE 300 253 20 4
ATORVASTATIN CALCIUM 288 261 21 17
METOPROLOL SUCCINATE 274 273 22 26
RISPERIDONE 274 233 22 49
DIGOXIN 247 242 24 52
IPRATROPIUM-ALBUTEROL 237 227 25 60
LANTUS 233 205 26 51
ESCITALOPRAM OXALATE 230 213 27 39
DIOVAN 226 209 28 32
OXYCODONE-ACETAMINOPHEN 215 144 S2 29 48
ATENOLOL 212 210 30 24
NAMENDA 212 212 30 62
DIVALPROEX SODIUM 186 162 32 74
TAMSULOSIN HCL 183 149 33 40
GLIPIZIDE 182 182 34 58
ALLOPURINOL 180 168 35 50
ZOLPIDEM TARTRATE 177 153 36 22
PROAIR HFA 173 110 37 3
PANTOPRAZOLE SODIUM 168 162 38 35
CARVEDILOL 166 155 39 41
METFORMIN HCL 165 129 40 23
OLANZAPINE 151 151 41 84
ISOSORBIDE MONONITRATE ER 151 151 41 69
HYDROCHLOROTHIAZIDE 147 122 43 20
CLOPIDOGREL 142 136 44 61
SEROQUEL 142 129 44 85
PHENYTOIN SODIUM EXTENDED 140 100 46 87
LEVOFLOXACIN 138 116 47 55
CRESTOR 136 130 48 37
SINGULAIR 136 108 48 6
AMOX TR-POTASSIUM CLAVULANATE 122 93 50 95
JANTOVEN 122 122 50 95
ABILIFY 121 120 52 98
CELEBREX 119 103 53 67
KLOR-CON M20 118 115 54 68
GLYBURIDE 117 106 R 55 56
NEXIUM 117 93 55 28
LIDODERM 117 105 55 77
TRAMADOL HCL 116 113 58 42
LOSARTAN POTASSIUM 113 113 59 34
DILTIAZEM 24HR CD 109 109 60 103
ALENDRONATE SODIUM 106 106 61 46
FLUTICASONE PROPIONATE 105 83 62 21
JANUVIA 105 93 62 104
HYDROCODONE-ACETAMINOPHEN 101 76 S3 64 38
LANSOPRAZOLE 101 96 64 105
RANITIDINE HCL 99 91 66 106
NOVOLIN R 98 91 67 107
SPIRONOLACTONE 98 94 67 75
AMOXICILLIN 94 75 69 82
LIPITOR 93 77 70 76
ZETIA 91 87 71 108
FENOFIBRATE 91 87 71 108
PAROXETINE HCL 91 90 71 86
ROPINIROLE HCL 89 88 74 66
FLUOXETINE HCL 86 86 75 113
MONTELUKAST SODIUM 85 69 76 13
ENALAPRIL MALEATE 84 82 77 78
PLAVIX 83 83 78 73
SYMBICORT 83 81 78 5
OXYCODONE HCL 83 68 S2 78 80
HUMALOG 82 76 81 115
TOPIRAMATE 79 79 82 116
FINASTERIDE 79 64 82 116
MELOXICAM 76 74 84 121
VESICARE 75 75 85 123
FENTANYL 73 54 S2 86 124
AZITHROMYCIN 72 61 87 14
NITROGLYCERIN PATCH 71 71 88 126
CIPROFLOXACIN HCL 70 57 89 87
LEVETIRACETAM 67 41 90 131
CARBIDOPA-LEVODOPA 67 67 90 79
CEPHALEXIN 67 56 90 131
LEXAPRO 66 64 93 91
DIOVAN HCT 66 57 93 92
DILTIAZEM ER 65 65 95 134
ACETAMINOPHEN-CODEINE 63 38 S3 96 135
CLOTRIMAZOLE-BETAMETHASONE 63 50 96 135
HYDROMORPHONE HCL 61 50 S2 98 138
DILANTIN 60 43 99 141
LEVOXYL 59 59 100 142
TRIAMTERENE-HCTZ 59 52 100 93
LOVASTATIN 58 58 102 64
METOLAZONE 58 57 102 143
DOXAZOSIN MESYLATE 58 58 102 101
TRICOR 58 53 102 143
OXYBUTYNIN CHLORIDE ER 56 56 106 146
PRAVASTATIN SODIUM 55 51 107 53
LYRICA 54 42 108 149
DOXYCYCLINE HYCLATE 53 49 109 72
METHENAMINE HIPPURATE 53 53 109 151
TRAVATAN Z 53 53 109 151
KETOCONAZOLE 51 50 112 156
LACTULOSE 50 39 113 158
ENABLEX 50 37 113 158
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 26, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.